IL131212A0 - Recombinant virus and live-virus vaccines - Google Patents

Recombinant virus and live-virus vaccines

Info

Publication number
IL131212A0
IL131212A0 IL13121299A IL13121299A IL131212A0 IL 131212 A0 IL131212 A0 IL 131212A0 IL 13121299 A IL13121299 A IL 13121299A IL 13121299 A IL13121299 A IL 13121299A IL 131212 A0 IL131212 A0 IL 131212A0
Authority
IL
Israel
Prior art keywords
virus
live
vaccines
recombinant
recombinant virus
Prior art date
Application number
IL13121299A
Original Assignee
Yissum Res Dev Co
Hadasit Med Res Service
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co, Hadasit Med Res Service filed Critical Yissum Res Dev Co
Priority to IL13121299A priority Critical patent/IL131212A0/en
Priority to EP20000949877 priority patent/EP1210448A1/en
Priority to CA 2381056 priority patent/CA2381056A1/en
Priority to AU63130/00A priority patent/AU6313000A/en
Priority to IL14784100A priority patent/IL147841A0/en
Priority to PCT/IL2000/000469 priority patent/WO2001009361A1/en
Priority to JP2001513617A priority patent/JP2003505103A/en
Publication of IL131212A0 publication Critical patent/IL131212A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16632—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16641—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16643—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
IL13121299A 1999-08-03 1999-08-03 Recombinant virus and live-virus vaccines IL131212A0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IL13121299A IL131212A0 (en) 1999-08-03 1999-08-03 Recombinant virus and live-virus vaccines
EP20000949877 EP1210448A1 (en) 1999-08-03 2000-08-03 Recombinant hsv-1 and live viral vaccines
CA 2381056 CA2381056A1 (en) 1999-08-03 2000-08-03 Recombinant hsv-1 and live viral vaccines
AU63130/00A AU6313000A (en) 1999-08-03 2000-08-03 Recombinant hsv-1 and live viral vaccines
IL14784100A IL147841A0 (en) 1999-08-03 2000-08-03 Recombinant hsv-1 and live viral vaccines
PCT/IL2000/000469 WO2001009361A1 (en) 1999-08-03 2000-08-03 Recombinant hsv-1 and live viral vaccines
JP2001513617A JP2003505103A (en) 1999-08-03 2000-08-03 Recombinant HSV-1 and live virus vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL13121299A IL131212A0 (en) 1999-08-03 1999-08-03 Recombinant virus and live-virus vaccines

Publications (1)

Publication Number Publication Date
IL131212A0 true IL131212A0 (en) 2001-01-28

Family

ID=11073099

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13121299A IL131212A0 (en) 1999-08-03 1999-08-03 Recombinant virus and live-virus vaccines

Country Status (6)

Country Link
EP (1) EP1210448A1 (en)
JP (1) JP2003505103A (en)
AU (1) AU6313000A (en)
CA (1) CA2381056A1 (en)
IL (1) IL131212A0 (en)
WO (1) WO2001009361A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE282708T1 (en) 2000-01-21 2004-12-15 Biovex Ltd HERPES VIRUS STRAINS FOR GENE THERAPY
JP2004532849A (en) * 2001-04-20 2004-10-28 カイロン コーポレイション Delivery of polynucleotide drugs to the central nervous system
JP2004099584A (en) 2002-05-02 2004-04-02 Keio Gijuku Antitumor agent using hsv
US7592169B2 (en) 2003-04-25 2009-09-22 Medimmune, Llc Methods and compositions for treatment and prevention of HSV-2 infections and conditions
WO2008030560A2 (en) * 2006-09-08 2008-03-13 The Trustees Of The University Of Pennsyvania Hsv-1 and hsv-2 vaccines and methods of use thereof
US8865185B2 (en) 2006-09-08 2014-10-21 The Trustees Of The University Of Pennsylvania Methods of use for HSV-1 and HSV-2 vaccines
US8057804B2 (en) 2006-12-28 2011-11-15 The Trustees Of The University Of Pennsylvania Herpes simplex virus combined subunit vaccines and methods of use thereof
EP2591800A1 (en) 2006-12-28 2013-05-15 The Trustees of The University of Pennsylvania Herpes simplex virus combined subunit vaccines and methods of use thereof
US10478490B2 (en) 2006-12-28 2019-11-19 The Trustees Of The University Of Pennsylvania Herpes simplex virus combined subunit vaccines and methods of use thereof
CN102657861A (en) * 2010-08-16 2012-09-12 郑州金森生物科技工程有限公司 Herpes simplex virus I-type gene recombinant attenuated live vaccine and preparation method thereof
DK2753355T3 (en) 2011-09-08 2019-01-28 Univ New York ONCOLYTIC HERP SIMPLEX VIRUSES AND THERAPEUTIC APPLICATIONS THEREOF
WO2016205429A1 (en) 2015-06-15 2016-12-22 New York University Method of treatment using oncolytic viruses
US20220154149A1 (en) * 2019-03-14 2022-05-19 Research Institute At Nationwide Children's Hospital Syncytial oncolytic herpes simplex mutants as potent cancer therapeutics
CN111635913B (en) * 2020-06-16 2022-03-04 广东东阳光药业有限公司 Construct and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9102126D0 (en) * 1991-01-31 1991-03-13 Smithkline Beecham Biolog Novel vaccine
US5804413A (en) * 1992-07-31 1998-09-08 University Of Pittsburgh Of The Commonwealth System Of Higher Education Herpes simplex virus strains for gene transfer
US5998174A (en) * 1997-05-12 1999-12-07 University Of Pittsburgh Of The Commonwealth System Of Higher Education Multigene vectors

Also Published As

Publication number Publication date
CA2381056A1 (en) 2001-02-08
AU6313000A (en) 2001-02-19
JP2003505103A (en) 2003-02-12
WO2001009361A1 (en) 2001-02-08
EP1210448A1 (en) 2002-06-05

Similar Documents

Publication Publication Date Title
CZ20011341A3 (en) Auxiliary preparations and vaccines
PT1150712E (en) Human papilloma virus vaccine formulations
GB9811433D0 (en) Virus vaccine
AU2003235707A8 (en) Immunogenic preparations and vaccines on the basis of mrna
HK1048493A1 (en) Genetically engineered bleb vaccine
IL148455A0 (en) Vaccine against hbv and hpv
ZA991662B (en) Recombinant and adjuvant-containing live vaccines.
AU4932601A (en) Recombinant parainfluenza virus expression systems and vaccines
IL148713A0 (en) Oral recombinant lactobacilli vaccines
IL148247A (en) Vaccine composition and uses thereof
IL131212A0 (en) Recombinant virus and live-virus vaccines
EP1204424A4 (en) Recombinant rsv virus expression systems and vaccines
HUP0202770A3 (en) Human papilloma virus vaccine
GB9901254D0 (en) Vaccines
IL148191A0 (en) Recombinant subunit vaccine
HUP0200560A2 (en) Bhv-1 gene-deleted virus vaccine
AU5913801A (en) Recombinant fusobacterium necrophorum leukotoxin vaccine and preparation thereof
GB9916794D0 (en) In vitro virus reconstitution
EP1224939A4 (en) Interferon complex and medicinal use thereof
GB9927353D0 (en) Virus preparation and use
GB9702990D0 (en) Virus vaccine
EP1229042A4 (en) Cyclic peptides and aids vaccines
GB9916702D0 (en) Virus vectors and preparations and their use
IL147841A0 (en) Recombinant hsv-1 and live viral vaccines
HUP9702540A3 (en) Carrying matherial for virus vaccine administered in intranasal way and virus vaccine itself